[BRKR] Bruker Corporation

Overview

Type of security: Stock

Sector: Capital Goods

Industry: Biotechnology: Laboratory Analytical Instruments

Market Capitalization: 4.03 B

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 21.53 Change: 0.13 (0.61%)
Ext. hours: Change: 0 (0%)

chart BRKR

Refresh chart

Strongest Trends Summary For BRKR

BRKR is in the medium-term up 57% in 1 year. In the long-term up 203% in 11 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Bruker Corporation, together with its subsidiaries, designs, manufactures, sells, and services proprietary life science and materials research systems, and associated products worldwide. It operates through two segments, Scientific Instruments, and Energy & Supercon Technologies. The Scientific Instruments segment offers instrumentation and automated solutions based on magnetic resonance, mass spectrometry, gas chromatography, X-ray, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology, and infrared and Raman molecular spectroscopy technologies. This segment serves pharmaceutical, biotechnology, and molecular diagnostic companies; academic institutions, medical schools, and other non-profit organizations; clinical microbiology laboratories; government departments and agencies; nanotechnology, semiconductor, chemical, cement, metals, and petroleum companies; and food, beverage, and agricultural analysis companies and laboratories. The Energy & Supercon Technologies segment

Fundamental Ratios
Shares Outstanding162.76 M EPS1.06 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -22.72% Sales Growth - Q/Q-30.41% P/E26.14
P/E To EPS Growth P/S2.32 P/BV5.63 Price/Cash Per Share8.19
Price/Free Cash Flow50.06 ROA3.07% ROE7.61% ROI4.44%
Current Ratio2.41 Quick Ratio1.54 Long Term Debt/Equity0.46 Debt Ratio0.76
Gross Margin42.78% Operating Margin5.75% Net Profit Margin3.13% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities4.1 M Cash From Investing Activities-5.7 M Cash From Operating Activities27 M Gross Profit160.2 M
Net Profit6.5 M Operating Profit15.2 M Total Assets1.77 B Total Current Assets1.3 B
Total Current Liabilities540.5 M Total Debt354.6 M Total Liabilities1.06 B Total Revenue353.5 M
Technical Data
High 52 week43.43 Low 52 week26.45 Last close41.33 Last change-2.48%
RSI62.07 Average true range1.45 Beta1.24 Volume306.96 K
Simple moving average 20 days2.21% Simple moving average 50 days5.07% Simple moving average 200 days18.35%
Performance Data
Performance Week-3.66% Performance Month8.38% Performance Quart9.15% Performance Half26.74%
Performance Year37.67% Performance Year-to-date38.83% Volatility daily2.96% Volatility weekly6.61%
Volatility monthly13.55% Volatility yearly46.95% Relative Volume101.22% Average Volume733.26 K
New High New Low

News

2019-09-16 04:00:00 | Bruker Announces Release of Breakthrough diaPASEF Workflow for CCS-aware 4D Proteomics on timsTOF™ Pro Platform at HUPO 2019

2019-09-12 09:09:01 | Bruker BRKR Introduces the nanoIR3-s Broadband System

2019-09-11 07:00:00 | Bruker Launches Nanoscale Infrared Spectroscopy and Chemical Imaging SNOM/AFM Microscopy System with Broadband Femtosecond IR Laser

2019-09-09 18:15:08 | Bruker Corp BRKR Pres. & CEO, Bruker EST Burkhard Prause Sold $674,558 of Shares

2019-09-05 07:19:27 | Need To Know: Bruker Corporation NASDAQ:BRKR Insiders Have Been Selling Shares

2019-09-03 09:19:01 | Bruker BRKR Releases JPK NanoWizard 4 XP Bio-AFM System

2019-09-02 07:00:00 | Bruker Launches Highest Resolution Large-Format Bio-AFM System

2019-08-31 09:31:01 | Bruker BRKR Down 7.4% Since Last Earnings Report: Can It Rebound?

2019-08-26 07:00:00 | Bruker Announces World's First 1.2 GHz High-Resolution Protein NMR Data

2019-08-18 09:39:25 | Does The Data Make Bruker Corporation NASDAQ:BRKR An Attractive Investment?

2019-08-12 07:00:00 | Bruker Announces Quarterly Dividend

2019-08-02 12:57:48 | Edited Transcript of BRKR earnings conference call or presentation 1-Aug-19 8:30pm GMT

2019-08-02 08:24:06 | Bruker BRKR Q2 2019 Earnings Call Transcript

2019-08-02 08:05:12 | Bruker BRKR Q2 Earnings Beat Estimates, Margins Expand

2019-08-01 18:25:10 | Bruker BRKR Beats Q2 Earnings and Revenue Estimates

2019-08-01 16:05:00 | Bruker Reports Second Quarter 2019 Financial Results

2019-07-31 10:40:02 | Garmin's GRMN Q2 Earnings & Revenues Surpass Estimates

2019-07-30 14:44:19 | At US$48.58, Is Bruker Corporation NASDAQ:BRKR Worth Looking At Closely?

2019-07-29 11:38:03 | Can Bruker BRKR Q2 Earnings See BioSpin's Growth Revival?

2019-07-29 09:30:01 | Is Bruker BRKR Outperforming Other Computer and Technology Stocks This Year?

2019-07-25 10:33:02 | Bruker BRKR Earnings Expected to Grow: Should You Buy?

2019-07-23 16:05:00 | Bruker Announces Date and Time of Second Quarter 2019 Earnings Release and Webcast

2019-07-17 07:00:00 | Bruker Comments on Block Trade Transaction

2019-07-11 11:10:03 | Illumina ILMN Grows on Innovation & International Growth

2019-07-11 07:19:11 | NuVasive NUVA Launches Pulse Integrated Technology Platform

2019-07-10 11:11:03 | Boston Scientific's Global Growth Robust Amid Currency Woe

2019-07-10 09:30:01 | Has Bruker BRKR Outpaced Other Computer and Technology Stocks This Year?

2019-07-10 08:22:12 | Medtronic Releases Positive Results of LATERAL Clinical Trial

2019-07-09 09:36:01 | ResMed RMD Rides on Strong SaaS Growth & New Product Suite

2019-07-09 09:30:01 | Integra Partners AI-Driven Data Analytics Firm in Wound Care

2019-07-09 08:18:12 | Phibro Animal Sees Crucial Progress in ASF Vaccine Development

2019-07-09 07:48:11 | Fresenius Set for Global Expansion of Research Activities

2019-07-08 10:34:02 | Illumina ILMN Hits 52-Week High, Can the Run Continue?

2019-07-08 10:29:02 | CVS Health Banks on Aetna Prospects, Omnicare May Disappoint

2019-07-08 10:25:02 | Boston Scientific to Sell Bead Suit, Make Way for BTG Buyout

2019-07-08 09:00:01 | Here's Why CVS Health CVS Should Be in Your Portfolio

2019-07-08 07:16:23 | Should We Be Delighted With Bruker Corporation's NASDAQ:BRKR ROE Of 20%?

2019-07-08 07:00:00 | Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies LLC

2019-07-05 08:05:12 | Here's Why Chemed CHE Should Remain in Your Portfolio Now

2019-07-02 18:18:10 | Five Runaway Breakout Stocks to Buy

2019-07-01 10:00:02 | Here's Why Bruker BRKR is a Great Momentum Stock to Buy

2019-06-28 10:41:02 | The Zacks Analyst Blog Highlights: Universal Display, Bruker, Match, j2 and Ciena

2019-06-27 08:30:12 | 5 Top Tech Gainers of 1H19

2019-06-26 08:06:12 | Here's Why You Should Add Bruker BRKR to Your Portfolio

2019-06-25 08:39:12 | Teleflex TFX Shares Down on Respiratory Care Product Recall

2019-06-25 08:38:12 | Bruker BRKR Hits a 52-Week High on Solid Growth Drivers

2019-06-24 09:00:01 | All You Need to Know About Bruker BRKR Rating Upgrade to Strong Buy

2019-06-24 08:25:12 | Methode Electronics MEI Q4 Earnings Lag, Sales Up Y/Y

2019-06-24 08:16:12 | Bruker BRKR Launches the MALDI Biotyper Sirius System

2019-06-24 07:00:00 | Bruker Announces New Phenomics Research Tools at Metabolomics 2019